Search - tctmd.com

Displaying 781 - 800 of 1104

Sort: Relevancy | Date

News Daily News

Apixaban Superior to Warfarin Regardless of A-fib Type, Duration

May 13, 2013

News Conference News SCAI 2013

POSEIDON: Sliding-Scale Hydration Prevents CIN, Adverse Events at 6 Months

Yael L. Maxwell

May 09, 2013

Presentation

POSEIDON: Sliding Scale Hydration for the Prevention of Contrast-Induced AKI

Presenter: Somjot S. Brar

May 09, 2013

News Daily News

Imaging Detects Vascular Injury Arising from Catheter-Based Renal Denervation

Caitlin E. Cox

May 03, 2013

News Daily News

ESC Offers Recommendations on Use of New Oral Anticoagulants

Yael L. Maxwell

May 03, 2013

Presentation

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Presenter: K. Tandjung

April 26, 2013

Presentation TCTAP 2013

The Future Is: New Antiplatelet Agents, Selective Platelet Function Testing, and Patient-Specific DAPT Duration

Presenter: Matthew J. Price

April 24, 2013

Presentation TCTAP 2013

Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive

Presenter: Adnan Kastrati

April 24, 2013

News Industry News

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

April 22, 2013

News Daily News

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

L.A. McKeown

April 19, 2013

News Daily News

Un Subestudio del Vorapaxar revela un Amplio Descenso de IM en Pacientes SCA de Alto Riesgo

L.A. McKeown

April 19, 2013

News Daily News

Subestudio ACT: La NAC No Reduce el Daño Renal en los Pacientes Diabéticos

April 19, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

News Daily News

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Caitlin E. Cox

April 19, 2013

News Daily News

La Colchicina Reduce la Reestenosis de los SMD en Pacientes Diabéticos

April 19, 2013

News Daily News

Colchicine Reduces BMS Restenosis in Diabetic Patients

April 19, 2013

News Daily News

ACT Substudy: NAC Does Not Reduce Kidney Damage in Diabetic Patients

April 19, 2013

Presentation

Acetylcysteine for the Prevention of Renal Outcomes in Patients with Diabetes Undergoing Coronary and Peripheral Angiography

Presenter: Otavio Berwanger

April 18, 2013

Presentation

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

Presenter: S. Deftereos

April 17, 2013

Presentation

Decision Dilemmas in Adjunctive Pharmacology Choices in PCI Patients

Presenter: Roxana Mehran

April 15, 2013

Advertisement

Apixaban Superior to Warfarin Regardless of A-fib Type, Duration

POSEIDON: Sliding-Scale Hydration Prevents CIN, Adverse Events at 6 Months

POSEIDON: Sliding Scale Hydration for the Prevention of Contrast-Induced AKI

Imaging Detects Vascular Injury Arising from Catheter-Based Renal Denervation

ESC Offers Recommendations on Use of New Oral Anticoagulants

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

The Future Is: New Antiplatelet Agents, Selective Platelet Function Testing, and Patient-Specific DAPT Duration

Counterpoint: The Incremental Benefit Is Small and the Cost-Disadvantages of New DAPT Approaches Are Prohibitive

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

Un Subestudio del Vorapaxar revela un Amplio Descenso de IM en Pacientes SCA de Alto Riesgo

Subestudio ACT: La NAC No Reduce el Daño Renal en los Pacientes Diabéticos

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

La Colchicina Reduce la Reestenosis de los SMD en Pacientes Diabéticos

Colchicine Reduces BMS Restenosis in Diabetic Patients

ACT Substudy: NAC Does Not Reduce Kidney Damage in Diabetic Patients

Acetylcysteine for the Prevention of Renal Outcomes in Patients with Diabetes Undergoing Coronary and Peripheral Angiography

Colchicine Treatment for Prevention of In-BMS Restenosis in Diabetics

Decision Dilemmas in Adjunctive Pharmacology Choices in PCI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content